ACTIVE

KL PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

50,7 k €

+3.4% YoY

Gross margin

90,1 k €

-1.7% YoY

Equity

384,6 k €

+15.2% YoY

What does KL PHARMA do?

KL PHARMA is a Private limited company incorporated in 2009. Its main activity is: Activities of holding companies. Its registered office is in Mont-de-l'Enclus.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0811.781.221

Incorporation

18/05/2009

Legal form

Private limited company

Registered office

Rue Couture d'Orroir(AM) 3
7750 Mont-de-l'Enclus · WallonieSee on map

Contributed capital

18 750,00 €

Latest accounts

31/12/2025

Activities (NACE)

64200Activities of holding companies· main 64210Activities of holding companies

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010
Income statement
Gross margin	90,1 k €	-1.7%	91,6 k €	+15.2%	79,5 k €	+27.5%	62,4 k €	-6.6%	66,8 k €	+23.3%	54,1 k €	+31.9%	41,1 k €	-10.6%	45,9 k €	-10.4%	51,3 k €	-3.4%	53,1 k €	-20.3%	66,7 k €	-3.1%	68,8 k €	-0.8%	69,4 k €	+9.5%	63,4 k €	-8.7%	69,4 k €	+11.7%	62,1 k €
EBITDA	88,8 k €	-1.8%	90,4 k €	+16.2%	77,8 k €	+27.4%	61,1 k €	-5.7%	64,8 k €	+22.6%	52,8 k €	+31.8%	40,1 k €	-11.1%	45,1 k €	-10.0%	50,1 k €	-3.0%	51,7 k €	-20.8%	65,2 k €	-3.4%	67,5 k €	-0.6%	67,9 k €	+9.6%	62 k €	-10.2%	69 k €	+11.8%	61,7 k €
Operating result	83,8 k €	+1.9%	82,3 k €	+18.1%	69,7 k €	+31.6%	52,9 k €	-6.6%	56,7 k €	+14.1%	49,7 k €	+23.9%	40,1 k €	-11.1%	45,1 k €	-9.1%	49,6 k €	-2.9%	51 k €	-15.2%	60,2 k €	-3.7%	62,5 k €	-0.7%	62,9 k €	+10.3%	57 k €	-11.8%	64,7 k €	+6.6%	60,7 k €
Net result	50,7 k €	+3.4%	49 k €	+25.5%	39 k €	+48.5%	26,3 k €	-5.8%	27,9 k €	+28.6%	21,7 k €	+48.2%	14,6 k €	-16.1%	17,5 k €	-2.8%	18 k €	+0.3%	17,9 k €	-23.3%	23,3 k €	-8.4%	25,5 k €	+7.2%	23,8 k €	+21.2%	19,6 k €	-20.7%	24,7 k €	+26.0%	19,6 k €
Balance sheet
Equity	384,6 k €	+15.2%	333,9 k €	-0.8%	336,7 k €	+13.1%	297,6 k €	+9.7%	271,3 k €	+11.5%	243,4 k €	+9.8%	221,7 k €	+7.1%	207,1 k €	+8.3%	191,2 k €	+10.4%	173,2 k €	+11.5%	155,3 k €	+17.7%	132 k €	+23.9%	106,5 k €	+28.7%	82,7 k €	+31.1%	63,1 k €	+64.4%	38,4 k €
Total assets	664,5 k €	+2.6%	647,6 k €	-1.2%	655,5 k €	+0.1%	655 k €	-1.4%	664,2 k €	+0.1%	663,3 k €	+5.7%	627,6 k €	-0.9%	633,1 k €	-3.4%	655,6 k €	-1.9%	668,1 k €	-3.8%	694,8 k €	-4.3%	725,9 k €	-3.7%	753,6 k €	-1.3%	763,9 k €	-0.2%	765,7 k €	+5.8%	723,8 k €
Cash	32,1 k €	-20.7%	40,4 k €	+81.4%	22,3 k €	+34.2%	16,6 k €	-39.1%	27,3 k €	+34.2%	20,3 k €	-2.2%	20,8 k €	-20.1%	26 k €	+18.8%	21,9 k €	-52.7%	46,4 k €	+153%	18,3 k €	-57.9%	43,5 k €	+18.7%	36,6 k €	-24.2%	48,3 k €	+38.5%	34,9 k €	+24.9%	27,9 k €
Debts	269,6 k €	-11.4%	304,5 k €	-1.9%	310,4 k €	-11.3%	349,9 k €	-9.3%	385,5 k €	-7.5%	416,7 k €	+3.2%	403,6 k €	-4.7%	423,7 k €	-7.5%	458,2 k €	-7.0%	492,6 k €	-8.3%	537,1 k €	-8.5%	587,2 k €	-8.9%	644,4 k €	-5.0%	678,6 k €	-2.5%	696,1 k €	+2.4%	679,7 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Katrien Vanhoutte

Director

Active

Ended mandates

KATRIEN VANHOUTTE

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
PHARMACIE VANHOUTTE● Active	0880.552.736

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Abridged model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	29/06/2026	30/06/2025	25/06/2024	28/06/2023	29/06/2022	13/07/2021
General meeting	27/06/2026	28/06/2025	22/06/2024	24/06/2023	25/06/2022	26/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	27/06/2026	29/06/2026	French	PDF
Micro model	31/12/2024	28/06/2025	30/06/2025	French	PDF
Micro model	31/12/2023	22/06/2024	25/06/2024	French	PDF
Micro model	31/12/2022	24/06/2023	28/06/2023	French	PDF
Abridged model	31/12/2021	25/06/2022	29/06/2022	French	PDF
Micro model	31/12/2020	26/06/2021	13/07/2021	French	PDF
Micro model	31/12/2019	27/06/2020	01/07/2020	French	PDF
Micro model	31/12/2018	22/06/2019	25/06/2019	French	PDF
Abridged model	31/12/2017	23/06/2018	16/07/2018	French	PDF
Micro model	31/12/2016	24/06/2017	29/06/2017	French	PDF
Abridged model	31/12/2015	25/06/2016	28/06/2016	French	PDF
Abridged model	31/12/2014	27/06/2015	01/07/2015	French	PDF
Abridged model	31/12/2013	28/06/2014	30/06/2014	French	PDF
Abridged model	31/12/2012	22/06/2013	27/06/2013	French	PDF
Abridged model	31/12/2011	23/06/2012	28/06/2012	French	PDF
Abridged model	31/12/2010	25/06/2011	27/06/2011	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 1 ended

Active mandates

Katrien Vanhoutte

Director

Active

Ended mandates

KATRIEN VANHOUTTE

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Other18/01/2023
OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Registered office03/05/2010
MAATSCHAPPELIJKE ZETEL
PDF
Other27/05/2009
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202550,7 k €↑
2024
Annual accounts 202449 k €↑
2023
Annual accounts 202339 k €↑
2022
Annual accounts 202226,3 k €↓
2021
Annual accounts 202127,9 k €↑
2020
Annual accounts 202021,7 k €↑
2019
Annual accounts 201914,6 k €↓
2018
Annual accounts 201817,5 k €↓
2017
Annual accounts 201718 k €↑
2016
Annual accounts 201617,9 k €↓
2015
Annual accounts 201523,3 k €↓
2014
Annual accounts 201425,5 k €↑
2013
Annual accounts 201323,8 k €↑
2012
Annual accounts 201219,6 k €↓
2011
Annual accounts 201124,7 k €↑
2010
Annual accounts 201019,6 k €
18/05/2009
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

KL PHARMA

Overview

What does KL PHARMA do?

Trend over 16 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline